Media Citizen's Blog

Just another weblog


leave a comment »

Sanofi-Aventis became the 3rd largest pharmaceutical behind GlaxoSmithKline and Pfizer after the 2004 merger between Sanofi and Aventis that created it.

Aventis was formed by two of the world’s largest chemical companies, Rhone-Poulenc of France and HoechstAG (#1) of Germany, merging their Life Sciences industry in 1999

Sanofi-Pasteur is the vaccine division ranked as the no.1 maker of vaccines in the world.

Sanofi-Aventis Group has its founding in the original Lyon establishment of the Merieux Biological Institute in 1897 by Marcel Merieux.

Institut Merieux, est.1897. Marcel Merieux was an assistant to Louis Pasteur whose Institut Pasteur in Paris was funded by Guy De Rothschild. Lyon became the French powerhouse city of industry during the Industrial Revolution, home to textile, dyestuff, chemical, and automotive manufacture and the “captains of industry” who ran them. The Merieux was created for the mass production of vaccines and reagents.

Lyon histoire,

Modern Merieux Timeline:

1897 – founding by Marcel Merieux,

1963 – creation of BD Merieux, owned equally by the Institute and Becton-Dickinson

1968 – chemical giant, Rhone-Poulenc, acquires 51% of Institut Merieux

1974 – Marcel’s grandson, Alain Merieux, takes over the business and renames it BioMerieux. BioMerieux is a world leader of ‘in vitro’ diagnostics

1985 – Pasteur Production, the vaccine division of Institut Pasteur, is acquired by Merieux which names it Pasteur Vaccins

1986 – acquisition of API Systems (la Balme, France)

1988 – acquisition of VITEK (McDonnel Douglas, US)

1989 – Merieux acquires Connaught Laboratories of Canada, and its subsidiaries. Connaught produced polio vaccine in the 1950s and acquired the Salk Institute Lab property in Swiftwater, PA.

1990 – the division of Pasteur Merieux Serums & Vaccins is created; becomes a wholly-owned subsidiary of Rhone-Poulenc with a 1994 name change to  Pasteur Merieux Connaught

1996 – collaboration with Affymetrix

1999 – Rhone-Poulenc and Hoechst merge to form Aventis

2001 – acquisition of Organon Teknika Diagnostic (Akzo Nobel, Netherlands)

2003 – strategic alliance with Cepheid and IDI

2004 – merger between Aventis and Sanofi; Sanofi-Pasteur becomes the vaccine division headquartered in Lyon with manufacturing headquarters in Swiftwater, Pennsylvania

2008 – Sanofi-Pasteur acquires Acambis, plc. biotech

Brief overview of the mergers behind Sanofi-Pasteur


Foundation Merieux, director Benoit Miribel, Donated a BSL-3 to the Weizmann Institute in 1993

The Fondation MérieuxAn independent foundation, it works to serve the interests of public health. Its mission is to help developing countries to combat infectious diseases.
website statistics

Since its creation, the foundation has advocated openness and partnership and has built a major international scientific network. It plays the role of catalyst in local and international initiatives working towards the same public health goals.

Charles Mérieux (1907-2001)

Charles Mérieux dedicated his life to preventive medicine and vaccinology, with unshakeable enthusiasm, determination, and imagination, nevertheless always based on the Pasteurian tradition.

“Tradition is not the ennemy but the support of audacity.” This quote from Pope John XXIII was the favorite one of Charles Mérieux.

Exert from Virus Passion, by Charles Merieux, Paris, Robert Laffont, 1997:

“Tradition is the Support of Innovation.”

” Beginning with a very modest laboratory and above all a bioethic to which I always remained faithful, I have experienced industrial virology with the same passion as my father experienced the epic of Pasteur. I’ve gone from the glass bottle to the steel vat, from foot-and-mouth disease to polio, from animal production to cellular engineering. ”

” But after the vaccination of a hundred million Brazilians against African meningitis, I understood that it was also necessary to teach capable men to lead a new health politic and develop the concept of vaccinology.”

The Fondation Mérieux

was set up in 1967 by Doctor Charles Mérieux, in memory of his father Marcel Mérieux, a pupil of Louis Pasteur and founder of the Mérieux Institute in 1897.
Conference Centre Les Pensieres

Located on the shores of Lake Annecy, France, Fondation Mérieux’s Les Pensières conference center was created to provide a place of work and discussion for those working in international public health, and in particular, the struggle to control infectious diseases.

Charles Mérieux created the Pensières Conference Center in his family property of Veyrier-du-Lac. Les Pensières was originally a dependency of the Abbey of Talloires. The oldest parts of the buildings date from the 16th Century, and were dedicated to wine-producing. The new buildings were designed and constructed in 1990 and 1992, and expanded in 2007-2008, to allow for development of the training and conference programs.

Exert from Virus Passion, by Charles Merieux, Paris, Robert Laffont, 1997:
“A Peaceful Heaven, Place of Beauty and Meditation.”
“A large meeting room, and a few prettily arranged rooms would suffice to make this place the ideal spot to welcome the scholars whom I count on receiving in the years ahead. Because the hotels lack soul and poetry, that the anonymous reception which is the same for all displeases me.”
“What I like is to share with others the pleasure that I find in exceptional sites and enjoy with them the atmosphere, which it exudes. And also to offer them a place where they will feel at ease, and which will bring them something new.” 



excerpt from “Second Thoughts About Disease”,

We found in our study of history that there is good evidence that Louis Pasteur’s position in the history of science may need considerable re-evaluation. E. Douglas Hume has demonstrated quite conclusively in her book, Bechamp or Pasteur (Hume, 1963), that the person who really developed the secrets of fermentation was a little known contemporary medical scientist named Bechamp. It is impossible to fully explain Bechamp’s complex hypotheses and findings covering 53 years of dedicated scientific research (1853-1905), and we do urge skeptical readers of our findings and interpretations to study his prolific works. In the year of his death. 1908, eight pages of the Moniteur Scientifique were required to set forth a list of his scientific works. Bechamp spoke of his last work. The Blood and Its Third Anatomical Element (Bechamp. 1912), “as the crown to a collection of works upon ferments and fermentation” which he had pursued without relaxation since 1854. On page 79 of this book Bechamp gives an interesting account of Pasteur:

“Now in 1872 M. Pasteur attempted his boldest plagiarism; he discovered all of a sudden eight years after my discovery thereof, (I will state elsewhere on what occasion) that the ferments of vineous fermentations exists naturally upon the grape. In this connection he discovered, also, that plant and animal matters contain normally the things which cause them to alter spontaneously, in their cellules. without the atmospheric germs. . .”

It appears to us that not only did Pasteur plagiarize, but he also distorted Bechamp’s hypothesis itself which we now offer to our readers in the spirit of continuing inquiry and of encouraging an objective re-evaluation of this man’s work in light of our current knowledge of the importance of nutrition-immunization interactions of the sort documented in the book, Every Second Child (Kalokerinos. 1974). Very briefly, it was Bechamp’s thesis that most disease is endogenous in origin or “born” within us and of us in the form of an enzyme transformation. Specifically, Bechamp proclaimed that special enzymes, which he called microzymas (soluble ferments), under certain conditions may evolve into viral or bacterial entities and that the latter may thus originate from within the organism, without seeding, as a permutation of the endogenous microzymas factors of the organism when conditions of nutritional breakdown are right to favor such change or microzymian evolution.



Rhone-Poulenc Rorer Parmaceuticals Inc., Collegeville Pennsylvania (RPR or RPRPI) CEO and Chairman Michel de Rosen

Rhone-Poulenc Rorer and Targacept Inc. collaborate to develop nicotinic-based drugs for Alzheimer’s and Parkinson’s


Hoecsht AG



Written by citizen2009

November 17, 2009 at 6:56 pm

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )


Connecting to %s

%d bloggers like this: